FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells
Authors
Keywords
-
Journal
ONCOGENE
Volume 36, Issue 24, Pages 3428-3440
Publisher
Springer Nature
Online
2017-01-24
DOI
10.1038/onc.2016.490
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype
- (2016) Feimeng Zheng et al. Nature Communications
- Correlation of Aurora-A expression with the effect of chemoradiation therapy on esophageal squamous cell carcinoma
- (2015) Kiyokazu Tamotsu et al. BMC CANCER
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance
- (2015) Gabriela Nestal de Moraes et al. CELLULAR SIGNALLING
- Non-malignant T-cells lacking multiple pan-T markers can be found in lymph nodes
- (2015) Wei Wang et al. LEUKEMIA & LYMPHOMA
- Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance
- (2015) P Khongkow et al. ONCOGENE
- Aurora kinase inhibitor patents and agents in clinical testing: an update (2011 – 2013)
- (2014) Chun Hei Antonio Cheung et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- A Novel Small Molecule Aurora Kinase Inhibitor Attenuates Breast Tumor-Initiating Cells and Overcomes Drug Resistance
- (2014) F.-M. Zheng et al. MOLECULAR CANCER THERAPEUTICS
- Overexpression of Forkhead Box Protein M1 (FOXM1) in Ovarian Cancer Correlates with Poor Patient Survival and Contributes to Paclitaxel Resistance
- (2014) Fung Zhao et al. PLoS One
- FOXM1: A key oncofoetal transcription factor in health and disease
- (2014) Laura Bella et al. SEMINARS IN CANCER BIOLOGY
- Lineage-restricted function of the pluripotency factor NANOG in stratified epithelia
- (2014) Daniela Piazzolla et al. Nature Communications
- Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas
- (2013) Jonathan W. Friedberg et al. JOURNAL OF CLINICAL ONCOLOGY
- FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance
- (2013) P Khongkow et al. ONCOGENE
- Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance
- (2013) Ana R. Gomes et al. Chinese Journal of Cancer
- A Brief Review on the Human Encyclopedia of DNA Elements (ENCODE) Project
- (2013) Hongzhu Qu et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Pediatric Phase I Trial and Pharmacokinetic Study of MLN8237, an Investigational Oral Selective Small-Molecule Inhibitor of Aurora Kinase A: A Children's Oncology Group Phase I Consortium Study
- (2012) Y. P. Mosse et al. CLINICAL CANCER RESEARCH
- Phase I Pharmacokinetic/Pharmacodynamic Study of MLN8237, an Investigational, Oral, Selective Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors
- (2012) A. Cervantes et al. CLINICAL CANCER RESEARCH
- Breast cancer stem cells
- (2012) Marco A. Velasco-Velázquez et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Aurora kinase inhibitors: Progress towards the clinic
- (2012) Madhu Kollareddy et al. INVESTIGATIONAL NEW DRUGS
- The Forkhead Transcription Factor FOXM1 Controls Cell Cycle-Dependent Gene Expression through an Atypical Chromatin Binding Mechanism
- (2012) X. Chen et al. MOLECULAR AND CELLULAR BIOLOGY
- Enhancing Chemosensitivity in ABCB1- and ABCG2-Overexpressing Cells and Cancer Stem-like Cells by An Aurora Kinase Inhibitor CCT129202
- (2012) Chao Cheng et al. MOLECULAR PHARMACEUTICS
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment
- (2012) L J Monteiro et al. ONCOGENE
- FOXM1: From cancer initiation to progression and treatment
- (2011) Chuay-Yeng Koo et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- ATM and p53 Regulate FOXM1 Expression via E2F in Breast Cancer Epirubicin Treatment and Resistance
- (2011) J. Millour et al. MOLECULAR CANCER THERAPEUTICS
- FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer
- (2011) C T Karadedou et al. ONCOGENE
- Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer
- (2009) U. B. McGovern et al. MOLECULAR CANCER THERAPEUTICS
- Cancer stem cells: mirage or reality?
- (2009) Piyush B Gupta et al. NATURE MEDICINE
- Inhibition of Aurora-A suppresses epithelial–mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells
- (2008) Xiang-Bo Wan et al. CARCINOGENESIS
- Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression
- (2008) J. M-M. Kwok et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now